{"transactions":[{"id":687489,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock (Right to Buy)","published_at":"2026-08-15T00:58:32.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":196276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":196276,"derivative":{"exercise_price":11.65,"expiration_date":"2036-08-14","underlying":"Common Stock","underlying_shares":196276},"source":{"system":"sec-edgar","filing":"0000711377-26-000016","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137726000016/primary_doc.xml","form_type":"4"}},{"id":687488,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-08-15T00:58:32.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":38627,"price":11.65,"value":450004.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"PSUs vest in total at the end of the three year anniversary date of the grant"}],"balance_after":38627,"source":{"system":"sec-edgar","filing":"0000711377-26-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137726000016/primary_doc.xml","form_type":"4"}},{"id":725335,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T20:21:41.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":0.576,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001628280-26-045784","document":"wk-form4_1782505299.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000162828026045784/wk-form4_1782505299.xml","form_type":"4"}},{"id":794767,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock (Right to Buy)","published_at":"2026-05-04T20:52:49.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":89520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":89520,"derivative":{"exercise_price":9.53,"expiration_date":"2036-05-01","underlying":"Common Stock","underlying_shares":89520},"source":{"system":"sec-edgar","filing":"0000711377-26-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137726000008/primary_doc.xml","form_type":"4"}},{"id":794766,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-05-04T20:52:49.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":39349,"price":9.53,"value":374995.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":39349,"source":{"system":"sec-edgar","filing":"0000711377-26-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137726000008/primary_doc.xml","form_type":"4"}},{"id":1113028,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T21:25:54.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":123500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":123500,"derivative":{"exercise_price":0.653,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":123500},"source":{"system":"sec-edgar","filing":"0001842952-25-000075","document":"wk-form4_1749763548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000184295225000075/wk-form4_1749763548.xml","form_type":"4"}},{"id":1478689,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T11:52:58.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":1.97,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-24-000048","document":"wk-form4_1718365971.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000184295224000048/wk-form4_1718365971.xml","form_type":"4"}},{"id":1873208,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-31T20:53:12.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":0.87,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-23-000060","document":"wf-form4_168556637918497.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000184295223000060/wf-form4_168556637918497.xml","form_type":"4"}},{"id":1986380,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-28T23:56:05.000Z","date":"2023-02-25","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 25, 2023."}],"balance_after":135000,"derivative":{"exercise_price":1.78,"expiration_date":"2033-02-24","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0000899243-23-006467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000089924323006467/doc4.xml","form_type":"4"}},{"id":2244027,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:09:13.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":2.19,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-22-000057","document":"wf-form4_165428693172276.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000184295222000057/wf-form4_165428693172276.xml","form_type":"4"}},{"id":2359895,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-02T21:06:01.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 28, 2022."}],"balance_after":75000,"derivative":{"exercise_price":2.24,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-22-008582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000089924322008582/doc4.xml","form_type":"4"}},{"id":2544276,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-13T00:20:02.000Z","date":"2021-10-08","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% on October 8, 2022, and in thirty-six (36) substantially equal monthly installments over a three year period thereafter."}],"balance_after":130000,"derivative":{"exercise_price":7.84,"expiration_date":"2031-10-07","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000899243-21-039956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000089924321039956/doc4.xml","form_type":"4"}}]}